Regulations.gov document
Development of Anti-Infective Drug Products for the Pediatric Population; Draft Guidance…
Notice · FDA-2020-D-1518 · posted Jun 30, 2020
Key facts
| Document ID | FDA-2020-D-1518-0001 |
|---|---|
| Title | Development of Anti-Infective Drug Products for the Pediatric Population; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2020-D-1518 |
| Posted | Jun 30, 2020 |
| Federal Register citation | 85 FR 39193 |
| FR document number | 2020-14085 |
| Comment period opens | Jun 30, 2020 |
| Comments due | Sep 1, 2020 |
| Effective date | Jun 30, 2020 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: